Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2017-08-11 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
106年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the first half of the year 2017 (民國106年上半年度) and the previous year period. It includes comprehensive financial data such as capital stock, capital surplus, retained earnings, and other equity components. The presence of actual financial figures and the focus on a half-year period indicate this is a financial report for an interim period rather than a brief announcement or a certification. The document length is 3363 characters, which is relatively short but contains substantive financial data, not just a notice or announcement. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-11 Chinese
106年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not contain any narrative, management discussion, or comprehensive financial data. It appears to be a regulatory disclosure or compliance update rather than a full report. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-08-10 Chinese
106年7月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month (July of 民國106, which corresponds to 2017) and compares it to the previous year. The document is short (763 characters) and provides substantive financial data rather than just an announcement or a link to a report. It is not a full annual or interim report but rather a periodic financial summary. Given the presence of actual financial figures and the nature of the data (monthly and cumulative revenue), this fits best as an Interim / Quarterly Report (IR). Q2 2017
2017-08-10 Chinese
公告本公司第三屆薪資報酬委員會委員
Board/Management Information Classification · 95% confidence The document is a short announcement (783 characters) about the appointment of members to the company's third Compensation Committee. It lists names, titles, and dates of appointment. There is no financial data, no report attached or referenced, and no mention of financial results or regulatory filings beyond the committee change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management committees.
2017-08-10 Chinese
公告本公司106年8月10日董事會通過之重要議案
Regulatory Filings Classification · 95% confidence The document is a short announcement from the company 景岳生物科技股份有限公司 dated 106/08/10 (Taiwan calendar year, equivalent to 2017). It reports that the board of directors approved the Q2 financial report and the appointment of a remuneration committee. The document is only 609 characters long and does not contain the actual financial statements or detailed financial data, but rather states that the Q2 financial report was approved. This fits the pattern of a Regulatory Filing (RNS) as it is a brief announcement of board decisions and does not include the full interim report itself. It is not a full Interim/Quarterly Report (IR) because it lacks substantive financial data. It is not a Report Publication Announcement (RPA) because it does not mention the report being attached or published elsewhere. Therefore, the best classification is Regulatory Filings (RNS).
2017-08-10 Chinese
106年07月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related information. The content focuses on personal share transactions and holdings by insiders rather than financial results, management commentary, or corporate governance policies. There is no indication of it being a full financial report, earnings release, or regulatory announcement about voting or dividends. The document is a report of personal share transactions and holdings by company directors and executives, which matches the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider shareholdings, not just an announcement or certification, so it is not RNS or RPA.
2017-08-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.